Chinese biotech Akeso (HKEX: 9926) has reported encouraging early data from a Phase III trial of its bispecific antibody ...

In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular | Drug Discovery And Development ...

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...

Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response ...

ASEAN Markets: Since August 2024, XPOVIO ® has been successively approved in Malaysia, Thailand, and Indonesia, marking significant progress in Antengene's commercialization strategy across the APAC ...

As diplomatic tensions continue between Canada and the United States, a travel group says Islanders are rethinking their travel plans, opting for alternative vacation destinations that are either ...